• Sonuç bulunamadı

Intracardiac fistula in a patient with prosthetic valve endocarditisProstetik kapak endokarditi olan bir olguda intrakardiyak fistül

N/A
N/A
Protected

Academic year: 2021

Share "Intracardiac fistula in a patient with prosthetic valve endocarditisProstetik kapak endokarditi olan bir olguda intrakardiyak fistül"

Copied!
1
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

107

Intracardiac fistula in a patient with prosthetic valve endocarditis

Prostetik kapak endokarditi olan bir olguda intrakardiyak fistül

A 44-year-old female patient pre-sented with fever, dyspnea, and pretibial edema 18 months after prosthetic aortic and mitral valve replacement. Transthoracic echo-cardiography (TTE) showed veg-etations on the aortic and mitral valves and moderate paravalvular aortic regurgitation between the right and noncoronary cusps, but no abscess formation. A probable pannus formation was also noted around the prosthetic mitral valve, along with moderate mitral ste-nosis. Blood cultures were positive for methicillin-sensitive

Staphylococcus aureus, and antibiotherapy (vancomycin 30 mg/

kg/day and gentamicin 3 mg/kg/day) was started. On the third day of treatment, the patient developed pulmonary edema and bedside TTE revealed severe aortic regurgitation. Thus, emergen-cy redo aortic and mitral valve replacement was performed. She was extubated on the first postoperative day, and her hemody-namic status was stable. Echocardiographic examination showed both prosthetic valves functioning normally. However, her clini-cal status deteriorated suddenly on the sixth postoperative day, resulting in cardiogenic shock. On TTE, a flow jet resembling

Ahmet Güler Soe Moe Aung Ali Karagöz Cevat Kırma

Department of Cardiology, Kartal Koşuyolu Heart and Research Hospital, İstanbul

Türk Kardiyol Dern Arş - Arch Turk Soc Cardiol 2012;40(1):107 doi: 10.5543/tkda.2012.01744

B C a tricuspid regurgitant jet was seen in the right atrium, but its origin was not clearly defined (Fig. A). Transesophageal echocardiography was performed, which showed aneurysmatic enlargement of the noncoronary sinus. A left-to-right shunt between the aorta and left-to-right atrium was noted (Fig. B, C; supplementary video file*). Despite an emergency operation and repair of the fistula with a synthetic graft, the patient died in the early postoperative period.

A

Figures.(A) Parasternal short-axis color flow image at the aortic valve level showing a jet in the right atrium. (B) Transesophageal echocardiography (short-axis view) showing an echolucent area (white arrow) between the aorta and right atrium. (C) A prominent jet (black arrow) is seen from the aorta into the right atrium.*Supplementary video file associated with this case can be found in the online version. RV: Right ventricle; RA: Right atrium; Ao: Aorta; LA: Left atrium.

Referanslar

Benzer Belgeler

On admission, echocardiography showed prolapse of the conjoined cusp and severe aortic regurgitation (AR) accompanied by an eccentric jet (Fig.. Careful observation revealed a

In our paper, we stated that the patient had a huge thrombus material blocking the movement of the aortic valve with resultant severe aortic stenosis; this detection was made in

(Ao-aorta). C) TOE reveals a completely disappearance of mitral regurgitation following Amplatzer occluder implantation (arrow) for PVL. D) 3D-TOE after successful deployment

To our knowledge, this patient is the first report of a case with co- ronary artery fistula and aneurysm formation with a history of aortic dissection repair, except for one case

Abiotrophia defectiva belongs to the nutritionally variant streptococci group and can colonize in oropharyngeal, gastrointestinal and genitourinary systems. Abiotrophia

Bilateral coronary ostial patch angioplasty with autologous pericardium in Takayasu arteritis: a case requiring replacement of the aortic valve and ascending

Quadricuspid aortic valves remain a rare congenital cardiac abnormality with an incidence of 0.001-0.04% on echocardiography.. [1] It may

We focus on the peri- and postoperative management of this rare coagulation disorder with a replacement therapy which included a recombinant activated coagulation factor VII